Rankings
▼
Calendar
PHAT Q3 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$891M
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$175,000
Operating Income
-$43M
Net Income
-$51M
EPS (Diluted)
$-1.54
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$202M
Total Liabilities
$228M
Stockholders' Equity
-$26M
Cash & Equivalents
$197M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$175,000
-$130,000
-34.6%
Operating Income
-$43M
-$33M
-28.3%
Net Income
-$51M
-$37M
-39.4%
← FY 2022
All Quarters
Q4 2022 →